Скачать
TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL
Автор: ecancer
Загружено: 2017-07-06
Просмотров: 325
Описание:
Dr Nastoupil talks with ecancer at EHA 2017 about the phase 1 trial that evaluates the safety/efficacy of the triplet combination of a novel anti-CD20 mAb PI3Kδ BTK inhibitor (ibrutinib) in pts with B-cell malignancies.
This is the first known triplet combination of an anti-CD20 mAb PI3Kδ BTK inhibitor. The combination of UTX, TGR-1202, and ibrutinib has been well tolerated with activity observed across heavily pre-treated and high-risk B-cell malignancies.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
